For 98 affective disorder patients receiving lithium prophylaxis for a
mean of 45 months, number of interepisode symptoms correlated with relapse
rate. Response to prophylaxis appeared highly determined by prelithium
frequency of episodes and duration of lithium treatment.
Abstract Teaser